Chemoinformaics analysis of Thymohydroquinone-Dimethylether
| Molecular Weight | 194.274 | nRot | 3 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 6 |
| Exact Molecular Weight | 194.131 | nRing | 1 |
| Solubility: LogS | -4.197 | nHRing | 0 |
| Solubility: LogP | 3.778 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 33.6463 |
| nHD | 0 | BPOL | 21.5297 |
| QED | 0.736 |
| Synth | 1.788 |
| Natural Product Likeliness | 0.058 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.08 |
| Pgp-sub | 0.407 |
| HIA | 0.006 |
| CACO-2 | -4.595 |
| MDCK | 0.0000214 |
| BBB | 0.733 |
| PPB | 0.959095 |
| VDSS | 1.992 |
| FU | 0.0357985 |
| CYP1A2-inh | 0.897 |
| CYP1A2-sub | 0.965 |
| CYP2c19-inh | 0.636 |
| CYP2c19-sub | 0.935 |
| CYP2c9-inh | 0.249 |
| CYP2c9-sub | 0.838 |
| CYP2d6-inh | 0.171 |
| CYP2d6-sub | 0.923 |
| CYP3a4-inh | 0.215 |
| CYP3a4-sub | 0.667 |
| CL | 9.192 |
| T12 | 0.408 |
| hERG | 0.017 |
| Ames | 0.074 |
| ROA | 0.082 |
| SkinSen | 0.131 |
| Carcinogencity | 0.347 |
| EI | 0.96 |
| Respiratory | 0.047 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.633303 |